StockData

BioLargo, Inc. (BLGO) stock

BLGOOTCChemicals & Allied ProductsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 0/30
$0.07+0.00 (+0.90%)

Close on Oct 19, 2026Market cap $23.27MP/E –Yield –

BioLargo operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

BioLargo's operating income for the twelve months ending Jun 30, 2026 was -$18.12M. For fiscal 2025 it was -$14.86M. The highest annual figure on record is -$2.62M in fiscal 2013.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$14.86M–
FY2024Dec 31, 2024-$4.33M–
FY2023Dec 31, 2023-$4.58M–
FY2022Dec 31, 2022-$5.39M–
FY2021Dec 31, 2021-$6.78M–
FY2020Dec 31, 2020-$7.58M–
FY2019Dec 31, 2019-$6.70M–
FY2018Dec 31, 2018-$6.41M–
FY2017Dec 31, 2017-$5.90M–
FY2016Dec 31, 2016-$4.93M–
FY2015Dec 31, 2015-$4.18M–
FY2014Dec 31, 2014-$3.39M–
FY2013Dec 31, 2013-$2.62M–
FY2012Dec 31, 2012-$4.72M–
FY2011Dec 31, 2011-$3.16M–
FY2010Dec 31, 2010-$4.20M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$3.73M–
Q1 FY2026Mar 31, 2026-$3.20M–
Q4 FY2025Dec 31, 2025-$4.01M–
Q3 FY2025Sep 30, 2025-$7.18M–
Q2 FY2025Jun 30, 2025-$1.80M–
Q1 FY2025Mar 31, 2025-$1.86M–
Q4 FY2024Dec 31, 2024-$1.62M–
Q3 FY2024Sep 30, 2024-$1.06M–
Q2 FY2024Jun 30, 2024-$890.00K–
Q1 FY2024Mar 31, 2024-$763.00K–
Q4 FY2023Dec 31, 2023-$1.01M–
Q3 FY2023Sep 30, 2023-$1.54M–
Q2 FY2023Jun 30, 2023-$1.56M–
Q1 FY2023Mar 31, 2023-$477.00K–
Q4 FY2022Dec 31, 2022-$1.42M–
Q3 FY2022Sep 30, 2022-$943.00K–
Q2 FY2022Jun 30, 2022-$1.32M–
Q1 FY2022Mar 31, 2022-$1.71M–
Q4 FY2021Dec 31, 2021-$1.77M–
Q3 FY2021Sep 30, 2021-$1.46M–
Q2 FY2021Jun 30, 2021-$1.70M–
Q1 FY2021Mar 31, 2021-$1.86M–
Q4 FY2020Dec 31, 2020-$1.97M–
Q3 FY2020Sep 30, 2020-$1.91M–
Q2 FY2020Jun 30, 2020-$2.01M–
Q1 FY2020Mar 31, 2020-$1.70M–
Q4 FY2019Dec 31, 2019-$1.66M–
Q3 FY2019Sep 30, 2019-$1.88M–
Q2 FY2019Jun 30, 2019-$1.49M–
Q1 FY2019Mar 31, 2019-$1.66M–
Q4 FY2018Dec 31, 2018-$1.51M–
Q3 FY2018Sep 30, 2018-$1.67M–
Q2 FY2018Jun 30, 2018-$1.63M–
Q1 FY2018Mar 31, 2018-$1.60M–
Q4 FY2017Dec 31, 2017-$1.50M–
Q3 FY2017Sep 30, 2017-$1.50M–
Q2 FY2017Jun 30, 2017-$1.47M–
Q1 FY2017Mar 31, 2017-$1.43M–
Q4 FY2016Dec 31, 2016-$1.20M–
Q3 FY2016Sep 30, 2016-$1.23M–

More BioLargo figures

See a number that looks wrong?